title: Comparison of three peripherally-inserted central catheters: pilot study.
abstract: Peripherally-inserted central catheters (PICCS) are non-tunnelled, central catheters inserted through a peripheral vein of the arm. They are 50-60 cm long and are usually made of either silicone or second-third generation polyurethane. PICCs can be used for prolonged, continuous or intermittent infusion therapies (up to 3 months) both in hospitalized patients and in patients treated as outpatients, in a hospice, or at home. When establishing a vascular service it is key to select a PICC that meets the requirements of safety, cost-effectiveness, high resistance (ability to take increasing fluid volumes with high pressure devices) and durability, and low complications rate. The complications and dwell times of three different PICCs were studied: coated polyurethane, valved silicone and power-injectable. The study was conducted at the chemotherapy suite at the author's hospital with the aim of selecting the right PICC based on low incidence of complications, resistance and enhanced dwell time. Results show a low incidence of complications and long dwell time among patients with the power-injectable PICC. Furthermore, this study demonstrated a reduction on the rate of occlusion and rupture with power-injectable PICCs, which makes them safer to use for administration of chemotherapy and other vesicant agents, as well as for the management of patients in critical care.
authors.affiliation: Macmillan Chemotherapy, Whittington Hospital NHS Trust, London.
authors.forename: Michele
authors.initials: M
authors.lastname: Di Giacomo
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002405:Catheterization, Central Venous / Q000295:instrumentation* / Q000451:nursing; D002406:Catheterization, Peripheral / Q000295:instrumentation* / Q000451:nursing; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000191:economics / Q000592:standards*; D002648:Child; D002675:Child, Preschool; D015400:Clinical Nursing Research; D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D004867:Equipment Design; D004868:Equipment Failure; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D008875:Middle Aged; D010689:Phlebitis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D010865:Pilot Projects; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors